(VIANEWS) – The Descartes Systems Group (DSGX), Imax Corporation (IMAX), Addus HomeCare Corporation (ADUS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. The Descartes Systems Group (DSGX)
16.9% sales growth and 10.28% return on equity
The Descartes Systems Group Inc. provides cloud-based logistics and supply chain management business process solutions that focuses on enhancing the productivity, performance, and security of logistics-intensive businesses worldwide. Its Logistics Technology platform offers a range of modular, cloud-based, and interoperable web and wireless logistics management applications, which unites a community of logistics-focused parties, allowing them to transact business. The company provides a suite of solutions that include routing, mobile and telematics; transportation management and e-commerce enablement; customs and regulatory compliance; trade data; global logistics network services; and broker and forwarder enterprise systems. It offers its customers to use its modular, software-as-a-service, and data solutions to route, schedule, track, and measure delivery resources; plan, allocate, and execute shipments; rate, audit, and pay transportation invoices; access and analyze global trade data; research and perform trade tariff and duty calculations; file customs and security documents for imports and exports; and various other logistics processes. The company also provides cloud-based ecommerce warehouse management solutions; consulting, implementation, and training services; and maintenance and support services. It primarily focuses on serving transportation providers, logistics service providers, and distribution-intensive companies, as well as manufacturers, retailers, distributors, and mobile business service providers. The company was incorporated in 1981 and is headquartered in Waterloo, Canada.
Earnings Per Share
As for profitability, The Descartes Systems Group has a trailing twelve months EPS of $1.31.
PE Ratio
The Descartes Systems Group has a trailing twelve months price to earnings ratio of 56.08. Meaning, the purchaser of the share is investing $56.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.28%.
Volume
Today’s last reported volume for The Descartes Systems Group is 24623 which is 77.88% below its average volume of 111357.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.6%, now sitting on 526.62M for the twelve trailing months.
Yearly Top and Bottom Value
The Descartes Systems Group’s stock is valued at $73.46 at 00:22 EST, way under its 52-week high of $82.02 and way higher than its 52-week low of $64.23.
Earnings Before Interest, Taxes, Depreciation, and Amortization
The Descartes Systems Group’s EBITDA is 115.42.
2. Imax Corporation (IMAX)
11.2% sales growth and 9.73% return on equity
IMAX Corporation, together with its subsidiaries, operates as an entertainment technology company that specializes in digital and film-based motion picture technologies worldwide. It offers cinematic solution comprising proprietary software, theater architecture, intellectual property, and equipment. The company offers Digital Re-Mastering (DMR), a proprietary technology that digitally enhances the image resolution, visual clarity, and sound quality of motion picture films for projection on IMAX screens; IMAX premium theater systems to exhibitor customers through sales, long-term leases, and joint revenue sharing arrangements; film post-production services; and camera and other miscellaneous items rental services, as well as distributes documentary films; and owns and operates IMAX theaters. It also designs, manufactures, installs, sells, and leases IMAX theater projection system equipment; maintains IMAX theater projection system equipment in the IMAX theater network; distributes and licenses original content, virtual reality, IMAX home entertainment, and others; and sells or leases its theater systems to theme parks, private home theaters, tourist destination sites, fairs, and expositions, as well as engages in the after-market sale of projection system parts and 3D glasses. The company markets its theater systems through a direct sales force and marketing staff. It owns or otherwise has rights to trademarks and trade names, which include IMAX, IMAX Dome, IMAX 3D, IMAX 3D Dome, Experience It in IMAX, The IMAX Experience, An IMAX Experience, An IMAX 3D Experience, IMAX DMR, DMR, IMAX nXos, and Films To The Fullest. As of March 31, 2020, the company had a network of 1,616 IMAX theater systems comprising 1,526 commercial multiplexes, 14 commercial destinations, and 76 institutional facilities operating in 81 countries and territories. IMAX Corporation was founded in 1967 and is headquartered in Mississauga, Canada.
Earnings Per Share
As for profitability, Imax Corporation has a trailing twelve months EPS of $0.45.
PE Ratio
Imax Corporation has a trailing twelve months price to earnings ratio of 39.87. Meaning, the purchaser of the share is investing $39.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.73%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 1.62%.
3. Addus HomeCare Corporation (ADUS)
10.3% sales growth and 8.5% return on equity
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.
Earnings Per Share
As for profitability, Addus HomeCare Corporation has a trailing twelve months EPS of $3.31.
PE Ratio
Addus HomeCare Corporation has a trailing twelve months price to earnings ratio of 23.84. Meaning, the purchaser of the share is investing $23.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.5%.
Sales Growth
Addus HomeCare Corporation’s sales growth is 10.3% for the present quarter and 10.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 14.9% and 3.6%, respectively.
4. Calix (CALX)
8.7% sales growth and 6.84% return on equity
Calix, Inc., together with its subsidiaries, provides cloud and software platforms, and systems and services in the United States, the Middle East, Canada, Europe, the Caribbean, and internationally. The company's cloud and software platforms, and systems and services enable communication service providers (CSPs) to provide a range of services. It provides Calix Cloud platform, a role-based analytics platform comprising Calix Marketing Cloud, Calix Support Cloud, and Calix Operations Cloud, which are configurable to display role-based insights and enable CSPs to anticipate and target new revenue-generating services and applications through mobile application. The company also offers EXOS, a carrier class smart home and business operating system that supports residential, business, and mobile subscribers; and AXOS, an operating system for access networks that allows a service provider to deliver all services on a single, elastic, converged access network that is always on, simple to operate, and quick to deploy. It offers its products through its direct sales force and resellers. Calix, Inc. was incorporated in 1999 and is headquartered in San Jose, California.
Earnings Per Share
As for profitability, Calix has a trailing twelve months EPS of $0.7.
PE Ratio
Calix has a trailing twelve months price to earnings ratio of 48.37. Meaning, the purchaser of the share is investing $48.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.84%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 1.02B for the twelve trailing months.
5. Northeast Community Bancorp (NECB)
7.8% sales growth and 15.94% return on equity
Northeast Community Bancorp, Inc. operates as the holding company for Northeast Community Bank that provides various financial services to consumers and businesses. The company accepts deposit products, such as checking, money market, savings, and individual retirement accounts, as well as certificates of deposit. Its loan products include multi-family, mixed-use, and real estate loans; commercial and industrial loans; construction loans; consumer loans; passbook, term, small business administration, and cooperative building loans; and revolving lines of credit. The company also offers various ATM/debit, credit, and gift cards; and investment advisory and financial planning, direct and remote deposit, wire transfer, automated clearing house, credit card merchant, coin and currency, and cash management services, as well as Internet, mobile, and telephone banking services. It operates three full-service branches in New York; three full-service branches in Massachusetts; one full service branch in Rockland County; two full service branch offices in Orange County; and a loan production office in New City, New York. The company was founded in 1934 and is headquartered in White Plains, New York. Northeast Community Bancorp, Inc. is a subsidiary of Northeast Community Bancorp, MHC.
Earnings Per Share
As for profitability, Northeast Community Bancorp has a trailing twelve months EPS of $2.92.
PE Ratio
Northeast Community Bancorp has a trailing twelve months price to earnings ratio of 5.47. Meaning, the purchaser of the share is investing $5.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.94%.
Volume
Today’s last reported volume for Northeast Community Bancorp is 104596 which is 62.49% above its average volume of 64370.
Moving Average
Northeast Community Bancorp’s worth is higher than its 50-day moving average of $15.24 and higher than its 200-day moving average of $14.73.
Sales Growth
Northeast Community Bancorp’s sales growth is 56.5% for the current quarter and 7.8% for the next.
Previous days news about Northeast Community Bancorp(NECB)
- According to Zacks on Tuesday, 7 November, "Northeast Community Bancorp Inc. price-consensus-chart | Northeast Community Bancorp Inc. Quote"
6. ICON plc (ICLR)
6.7% sales growth and 5.97% return on equity
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. The company's clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional solutions, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON has an agreement with Evergreen Therapeutics, Inc. to conduct Phase II clinical trial for COVID-19 drug candidate. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, ICON plc has a trailing twelve months EPS of $6.21.
PE Ratio
ICON plc has a trailing twelve months price to earnings ratio of 42.16. Meaning, the purchaser of the share is investing $42.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.97%.
Yearly Top and Bottom Value
ICON plc’s stock is valued at $261.83 at 00:22 EST, below its 52-week high of $268.07 and way above its 52-week low of $181.92.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.8%, now sitting on 8.02B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ICON plc’s EBITDA is 3.08.
Volume
Today’s last reported volume for ICON plc is 210003 which is 61.61% below its average volume of 547154.
7. HealthStream (HSTM)
5.1% sales growth and 3.89% return on equity
HealthStream, Inc. provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the range of its clinical development, talent management, training, certification, scheduling, competency assessment, performance appraisal, and other needs, as well as implementation and account management services. It also provides applications for learning, compensation management, succession planning, competency management, disclosure management, simulation-based education, quality management, and industry training. In addition, the company offers VerityStream that delivers enterprise-class solutions to transform the healthcare provider experience for ambulatory surgery centers, urgent care facilities, clinics, medical groups, and other healthcare organizations; EchoCredentialing and MSOW platforms that manage medical staff credentialing, enrollment, and privileging processes for hospitals; and EchoOneApp, a provider enrollment platform for medical groups. Further, it provides CredentialMyDoc, a credentialing and enrollment SaaS solution for medical groups and surgery centers; CredentialStream, a SaaS-based provider credentialing, privileging, and enrollment solution; and NurseGrid Mobile for nurse managers. The company offers its solutions in healthcare industry companies that include private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through direct sales teams. HealthStream, Inc. was incorporated in 1990 and is headquartered in Nashville, Tennessee.
Earnings Per Share
As for profitability, HealthStream has a trailing twelve months EPS of $0.43.
PE Ratio
HealthStream has a trailing twelve months price to earnings ratio of 59.91. Meaning, the purchaser of the share is investing $59.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.89%.
Sales Growth
HealthStream’s sales growth is 3.3% for the current quarter and 5.1% for the next.
